-+ 0.00%
-+ 0.00%
-+ 0.00%

XBIOTECH LAUNCHES PHASE II CLINICAL TRIAL EVALUATING VILAMAKITUG FOR THE TREATMENT OF ACTIVE AXIAL SPONDYLOARTHRITIS

Reuters·06/15/2026 13:00:00

Please log in to view news